印度药典委员会签署了谅解备忘录,以提高医疗安全和质量. Indian Pharmacopoeia Commission signs MoUs to improve medicine safety and quality.

印度药典委员会 (IPC) 签署了两份谅解备忘录,以加强药品质量和安全性. The Indian Pharmacopoeia Commission (IPC) has signed two memoranda of understanding (MoUs) to strengthen medicine quality and safety. 印度药品和医疗器械局 (PMBI) 的一项合作将通过随机测试和扩大药物监督工作来改善政府的Jan Aushadhi中心销售药物的监管. One with the Pharmaceuticals & Medical Devices Bureau of India (PMBI) will improve oversight of medicines sold through government Jan Aushadhi Kendras by enabling random testing and expanding pharmacovigilance efforts. 尼珀与哈吉普尔的第二项协议重点是药物科学领域的合作研究, 包括生物制剂标准制定和处理杂质分析以促进公共卫生安全. The second agreement with NIPER Hajipur focuses on collaborative research in pharmaceutical science, including developing standards for biologics and addressing impurity profiling to advance public health safety.